Innovassynth Technologies: Q1 FY27 Results

Innovassynth Technologies reported a net profit of ₹6.74 crore for the first quarter of fiscal year 2027 (ending June 30, 2026). This marks a significant turnaround from a net loss of ₹18.67 crore in the corresponding quarter of the previous fiscal year (Q1 FY26).

The company's revenue from operations for Q1 FY27 stood at ₹55.99 crore. This represents substantial year-on-year growth from ₹12.27 crore in Q1 FY26 and a sequential increase from ₹50.83 crore in the preceding quarter (Q4 FY26).

Reader Takeaway: Year-on-year profit turnaround and revenue growth; sequential profit dip needs monitoring.

What just happened

Innovassynth Technologies announced its financial results for the quarter ended June 30, 2026. The company reported a net profit of ₹6.74 crore on revenues of ₹55.99 crore. This contrasts with a net loss of ₹18.67 crore in the same quarter last year. The company also completed a rights issue of ₹69.65 crore in May 2026.

Why this matters

The results show a positive trajectory for Innovassynth Technologies, moving from a loss-making position in the prior year's quarter to profitability. The increased revenue and completed capital infusion through the rights issue suggest strengthening operational and financial capabilities. This turnaround is a key development for investors monitoring the company's performance.

The backstory

In the first quarter of fiscal year 2026 (June 2025), Innovassynth Technologies had reported a net loss of ₹18.67 crore on revenue of ₹12.27 crore. The company has been focusing on its specialty chemicals and pharmaceutical intermediates business.

What changes now

The company's return to profitability and increased revenue in Q1 FY27, bolstered by the capital from the rights issue, positions it for potential future growth. Investors will be looking for sustained performance and improved profitability in subsequent quarters.

Risks to watch

While the year-on-year performance is positive, the sequential decline in net profit from ₹11.95 crore in Q4 FY26 to ₹6.74 crore in Q1 FY27 warrants attention. This could indicate increased operational costs or other factors impacting margins in the short term.

Peer comparison

(No verified peer comparison data available from the filing.)

Context metrics (time-bound)

• Revenue (Q1 FY27): ₹55.99 crore
• Net Profit (Q1 FY27): ₹6.74 crore
• EPS (Q1 FY27): ₹0.80
• Rights Issue Completion: ₹69.65 crore (May 2026)
• Revenue (Q1 FY26): ₹12.27 crore
• Net Loss (Q1 FY26): ₹18.67 crore

What to track next

Investors should closely monitor the company's ability to sustain revenue growth and improve its sequential profitability. Tracking the utilization of the funds raised through the rights issue and its impact on future earnings will also be crucial.